Intellectual property is the cornerstone to early-stage deal making in the life science industry and by owning, or to have exclusive rights to a key patent or a patent, a company are able to exclude its chief competitors from the marketplace.

Our distinguished speaker panel with companies such as NKT Holding, UCB Group, Genmab, H. Lundbeck, Boston University, Plougmann & Vingtoft and Zacco Sweden will guide you from the early stage freedom to operate search to set up an FTO strategy to collaborate and make licensing deals with partners and competitors.